SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

TMC the metals co., Inc. is a deep-sea minerals exploration company focused on the collection and processing of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone in the Pacific Ocean (CCZ). These nodules contain high grades of four metals (nickel, copper, cobalt, manganese) which can be used as (i) feedstock for battery cathode precursors (nickel, cobalt and manganese sulfates, or intermediate nickel-copper-cobalt matte) for electric vehicles (EV) and renewable energy storage markets, (ii) copper cathode for EV wiring, energy transmission and other applications and (iii) manganese silicate for manganese alloy production required for steel production. The company was founded in 2021 and is headquartered in Vancouver, Canada.

TMC the metals company Inc

TMC is trending as recent actions by NOAA to streamline deep-sea mining permits ignite speculation of a faster path to commercial recovery for U.S. companies. The community is highly bullish, viewing critical deep-sea minerals as a national security priority, and is actively discussing the potential for a short squeeze ahead of an upcoming Congressional hearing featuring TMC's CEO.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is currently surging, fueled by recent analyst upgrades, substantial government support for its US-based foundries, and intense speculation around potential major partnerships. Community sentiment is sharply divided, with jubilant bulls celebrating significant gains and anticipating a massive turnaround, while others warn of an unsustainable rally ahead of its anticipated earnings report.

ProShares Trust - ProShares Ultra Bloomberg Natural Gas 2x Shares

ProShares Ultra Bloomberg Natural Gas

ProShares Ultra Bloomberg Natural Gas ($BOIL) is trending amid an extreme arctic cold front and polar vortex sweeping across the U.S., significantly driving up natural gas demand and futures prices. The community is actively discussing intense price volatility, the potential for a short squeeze, and the impact on natural gas storage levels, while also highlighting the inherent "widow maker" risks of leveraged natural gas ETFs.

MiMedx Group, Inc. is a therapeutic biologics company, which engages in the design, manufacture, and marketing of products, and tissue processing services. It serves the wound care, burn, surgical, orthopedic, spine, sports medicine, ophthalmic, and dental sectors of healthcare. Its biomaterial platform technologies include AmnioFix and EpiFix, a tissue allografts derived from amnion and chorion layers of human placental membrane, EpiCord and AmnioCord, a tissue allografts derived from umbilical cord tissue, and AmnioFill, a placental connective tissue matrix derived from the placental disc and other placental tissue. The company was founded on July 30, 1985 and is headquartered in Marietta, GA.

Mimedx Group Inc

MiMedx Group is trending amid significant community concern over upcoming CMS reimbursement changes set to impact high-average selling price wound care products in 2026. Discussions highlight widespread bearish sentiment, with many anticipating substantial revenue declines and raising allegations of past billing improprieties involving products like Celera and Emerge. This regulatory uncertainty compounds frustration over the company's declining stock performance and perceived lack of communication from management regarding strategic responses or buybacks.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is trending after a Neutron rocket Stage 1 tank rupture during qualification testing, sparking a polarized debate among investors. While bulls interpret this as a normal and necessary part of stress testing, highlighting the company's robust Electron launch record and significant defense contracts, bears are concerned about potential delays to the Neutron program and a possible stock correction.

ProShares Trust - ProShares UltraShort Bloomberg Natural Gas -2x Shares

ProShares UltraShort Bloomberg Natural Gas

KOLD is experiencing extreme volatility as natural gas prices surge due to forecasts of an intense Arctic freeze across the U.S. The community is actively discussing entry and exit points, keenly aware of the "widow maker" reputation of these leveraged ETFs amid dramatic price swings. Many are attempting to capitalize on the rapid moves, while others caution against the inherent risks of such instruments.

PAVmed, Inc. is a multi-product life sciences company, which engages in the innovation, development, acquisition, and commercialization of products that target unmet medical needs with large addressable market opportunities. Its products include Lucid Diagnostics and Veris Health. The company was founded by Lishan Aklog and Brian J. deGuzman on June 26, 2014 and is headquartered in New York, NY.

PAVmed Inc

PAVmed is currently trending following its subsidiary, Lucid Diagnostics, securing a contract with the U.S. Department of Veterans Affairs for its EsoGuard Esophageal DNA Test, significantly expanding access to esophageal precancer screening. This news has sparked considerable community excitement, with traders noting the stock's low float and discussing the potential for a substantial short squeeze, drawing comparisons to other recent explosive movers in the market.

Corvus Pharmaceuticals, Inc. engages in the development of immune modulator product candidates with the potential to treat solid cancers, T-cell lymphomas, autoimmune diseases, and infectious diseases. Its product pipeline includes B Cell Activator and Anti-CD73, Adenosine Production Inhibitor Anti-CD73, ITK Inhibitor, A2AR Inhibitor, Anti-CXCR2, and A2BR Inhibitor. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

Corvus Pharmaceuticals Inc

Corvus Pharmaceuticals is actively trending due to compelling Phase 1 clinical trial data for its eczema treatment, soquelitinib, which sparked a significant price surge. This momentum is now challenged by a proposed $150 million public offering, causing a sharp divide among investors. Community discussions are intensely focused on the potential for massive dilution versus the drug's long-term promise and the possibility of a short squeeze.

Cipher Mining, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business. The company was founded in 2021 and is headquartered in New York, NY.

Cipher Mining Inc

Cipher Mining is trending due to its significant expansion into the AI/HPC data center sector, highlighted by an Ohio site acquisition and strategic deals with hyperscalers. The community is actively discussing CIFR's strategic pivot from solely Bitcoin mining, anticipating its role as a critical power backbone for the accelerating AI boom. This focus on infrastructure and substantial contracted revenue from major tech players fuels optimism amidst ongoing discussions about market volatility.

Under Armour, Inc. engages in the development, marketing, and distribution of branded performance apparel, footwear, and accessories for men, women, and youth. It operates through the following geographical segments: North America, EMEA, Asia-Pacific, Latin America, and Other. The company was founded by Kevin A. Plank in 1996 and is headquartered in Baltimore, MD.

Under Armour Inc - Ordinary Shares - Class C

Under Armour Inc Class C

Under Armour is trending following significant insider buying by Fairfax Financial Holdings, which has reportedly accumulated over a 22% stake, signaling strong confidence in the athletic apparel brand. This substantial investment, alongside considerable short interest, is driving community speculation about a potential short squeeze and the stock being undervalued. Investors are actively discussing the company's ongoing restructuring efforts and revised financial outlook, hoping for a turnaround in its market performance.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Axon Enterprise (AXON) Stock Sinks As Market Gains: What You Should Know

In the latest trading session, Axon Enterprise (AXON) closed at $610.4, marking a -1.63% move from the previous day.

2,720 Shares in Axon Enterprise, Inc $AXON Purchased by Allstate Corp

Allstate Corp acquired a new position in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange...

McBroom & Associates LLC Buys 4,195 Shares of Axon Enterprise, Inc $AXON

McBroom & Associates LLC grew its stake in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 131.5% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange...

Stephens Investment Management Group LLC Trims Stock Holdings in Axon Enterprise, Inc $AXON

Stephens Investment Management Group LLC lessened its position in shares of Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 20.4% during the 3rd quarter, according to the company in its most...

Axon Enterprise (AXON) Sees a More Significant Dip Than Broader Market: Some Facts to Know

Axon Enterprise (AXON) closed at $629.22 in the latest trading session, marking a -1.92% move from the prior day.

SG Americas Securities LLC Has $2.99 Million Holdings in Axon Enterprise, Inc $AXON

SG Americas Securities LLC lowered its stake in shares of Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 54.6% in the third quarter, according to its most recent 13F filing with the SEC. The...

Is Trending Stock Axon Enterprise, Inc (AXON) a Buy Now?

Axon (AXON) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Axon Enterprise (AXON) closed at $612.98 in the latest trading session, marking a -1.28% move from the prior day.

Axon Enterprise, Inc $AXON Shares Purchased by Robeco Institutional Asset Management B.V.

Robeco Institutional Asset Management B.V. raised its holdings in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 28.2% during the third quarter, according to the company in its most recent Form...

Axon Enterprise, Inc $AXON Shares Sold by Commonwealth Equity Services LLC

Commonwealth Equity Services LLC lowered its position in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 11.3% in the third quarter, according to the company in its most recent disclosure with...

Axon Enterprise, Inc. engages in the development, manufacture, and sale of conducted electrical weapons for personal defense. It operates through the TASER segment and Software and Sensors segment. The TASER segment sells conducted electrical weapons, accessories, and other related products and services. The Software and Sensors segment includes devices, wearables, applications, cloud, and mobile products. The company was founded by Patrick W. Smith and Thomas P. Smith on September 7, 1993 and is headquartered in Scottsdale, AZ.

Axon Enterprise Inc

Up 10% or more

0% to up 9%

Down 1% to 9%

Down 10% or more

The S&P 500 enters 2026 after a strong run. What kind of return do you expect this year?

How will the S&amp;P 500 perform in 2026?

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	$1.60	--	--	N/A
Q3 '25	$1.52	$1.17	-23.05%	MISSED
Q2 '25	$1.45	$2.12	45.71%	BEAT
Q1 '25	$1.27	$1.41	10.70%	BEAT
Q4 '24	$1.40	$2.08	48.15%	BEAT

AXON
Axon Enterprise Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest AXON News

AXONAxon Enterprise Inc